The compounds of the invention include all compounds including polypeptides so long as they can bind to the receptors.The invention is described below referring to variant maxadilans, but the invention is not limited thereto.According to the above screening method of the invention, one selected from the group consisting ofa) such a polypeptide that, in the amino acid sequence represented by SEQ ID